(Q55036456)

16 June 2018

title

Serum iron levels in schizophrenic patients with or without akathisia. (English)

1 reference

16 June 2018

0 references

2

Murad Atmaca

1 reference

16 June 2018

A Ertan Tezcan

6

object named as

Ertan Tezcan

1 reference

16 June 2018

Murat Kuloglu

1

object named as

Murat Kuloglu

1 reference

16 June 2018

Omer Gecici

5

object named as

Omer Gecici

1 reference

16 June 2018

author name string

Bilal Ustündag

3

1 reference

16 June 2018

Halit Canatan

4

1 reference

16 June 2018

language of work or name

English

0 references

publication date

1 March 2003

1 reference

16 June 2018

European Neuropsychopharmacology

published in

1 reference

16 June 2018

volume

13

1 reference

16 June 2018

page(s)

67-71

1 reference

16 June 2018

issue

2

1 reference

16 June 2018

A rating scale for drug-induced akathisia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900073-1

7 January 2021

Relationship between iron status and chronic akathisia in an in-patient population with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900073-1

7 January 2021

Low plasma iron status and akathisia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900073-1

7 January 2021

Effect of iron chelators on dopamine D2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900073-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900073-1

1 reference

7 January 2021

Low serum iron status and akathisia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900073-1

7 January 2021

Serum iron and ferritin in acute neuroleptic akathisia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900073-1

7 January 2021

Serum iron levels and akathisia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900073-1

7 January 2021

Serum iron and transferrin in acute neuroleptic induced akathisia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900073-1

7 January 2021

Iron, akathisia, and antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900073-1

7 January 2021

The epidemiology of drug-induced akathisia: Part II. Chronic, tardive, and withdrawal akathisias.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900073-1

7 January 2021

Acute drug-induced akathisia is not associated with low serum iron status

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900073-1

7 January 2021

A case of suicidal and homicidal ideation and akathisia in a double-blind neuroleptic crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900073-1

7 January 2021

Serum iron abnormalities in neuroleptic-induced akathisia in schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900073-1

7 January 2021

Tardive akathisia associated with low-dose haloperidol use

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900073-1

7 January 2021

The many faces of Akathisia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900073-1

7 January 2021

Iron deficiency during early development in the rat: behavioral and physiological consequences.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900073-1

7 January 2021

10.1016/S0924-977X(02)00073-1

Identifiers

DOI

1 reference

16 June 2018

PubMed ID

12650948

1 reference

16 June 2018